Your browser is no longer supported. Please, upgrade your browser.
Opiant Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-0.10 Insider Own0.10% Shs Outstand4.26M Perf Week16.45%
Market Cap42.01M Forward P/E- EPS next Y-1.94 Insider Trans254.24% Shs Float4.02M Perf Month24.69%
Income-0.10M PEG- EPS next Q0.07 Inst Own31.10% Short Float0.23% Perf Quarter36.18%
Sales27.40M P/S1.53 EPS this Y130.60% Inst Trans- Short Ratio0.15 Perf Half Y9.84%
Book/sh8.35 P/B1.20 EPS next Y-781.80% ROA-0.30% Target Price- Perf Year-21.18%
Cash/sh7.44 P/C1.35 EPS next 5Y- ROE-0.30% 52W Range6.79 - 13.70 Perf YTD25.16%
Dividend- P/FCF- EPS past 5Y20.70% ROI32.30% 52W High-26.64% Beta0.88
Dividend %- Quick Ratio6.10 Sales past 5Y92.10% Gross Margin78.40% 52W Low48.06% ATR0.42
Employees21 Current Ratio6.10 Sales Q/Q-55.80% Oper. Margin-1.60% RSI (14)76.78 Volatility5.89% 4.09%
OptionableNo Debt/Eq0.00 EPS Q/Q-92.40% Profit Margin-0.40% Rel Volume2.06 Prev Close9.33
ShortableYes LT Debt/Eq0.00 EarningsNov 12 AMC Payout- Avg Volume62.24K Price10.05
Recom2.00 SMA2018.02% SMA5020.43% SMA20011.64% Volume127,945 Change7.72%
May-29-19Initiated Northland Capital Outperform
Dec-15-20 07:52AM  
Dec-14-20 04:01PM  
Dec-10-20 04:01PM  
Dec-07-20 04:01PM  
Nov-27-20 09:58AM  
Nov-17-20 06:16AM  
Nov-12-20 04:41PM  
Nov-02-20 04:01PM  
Oct-29-20 04:05PM  
Oct-27-20 04:01PM  
Sep-21-20 09:56AM  
Sep-14-20 09:46AM  
Aug-31-20 04:05PM  
Aug-24-20 03:50PM  
Aug-17-20 11:46AM  
Aug-10-20 07:45AM  
Aug-06-20 04:05PM  
Jul-23-20 04:01PM  
Jun-30-20 07:08PM  
Jun-08-20 04:14PM  
Jun-07-20 03:36AM  
Jun-05-20 09:37PM  
Jun-04-20 06:40PM  
May-26-20 04:05PM  
May-25-20 12:59PM  
May-21-20 04:05PM  
May-15-20 06:06AM  
May-12-20 04:05PM  
Apr-28-20 08:00AM  
Mar-26-20 02:57PM  
Mar-25-20 11:09PM  
Mar-09-20 07:15AM  
Mar-04-20 04:05PM  
Feb-24-20 04:01PM  
Jan-24-20 09:32AM  
Jan-06-20 04:26PM  
Jan-02-20 08:00AM  
Dec-12-19 04:05PM  
Dec-10-19 12:07PM  
Nov-24-19 04:25PM  
Nov-13-19 08:40AM  
Nov-12-19 04:05PM  
Nov-05-19 08:00AM  
Oct-14-19 02:14PM  
Oct-10-19 08:00AM  
Sep-24-19 04:05PM  
Sep-17-19 08:00AM  
Sep-12-19 11:25AM  
Aug-27-19 04:30PM  
Aug-19-19 06:02PM  
Aug-13-19 10:10AM  
Aug-08-19 04:05PM  
Jul-30-19 04:30PM  
Jul-29-19 01:04PM  
Jul-23-19 08:00AM  
Jun-14-19 01:44PM  
May-25-19 07:25AM  
May-13-19 12:45PM  
May-09-19 04:05PM  
Apr-30-19 04:05PM  
Apr-28-19 09:53AM  
Apr-15-19 11:45AM  
Apr-12-19 10:13AM  
Apr-08-19 08:00AM  
Apr-03-19 08:00AM  
Apr-01-19 08:00AM  
Mar-28-19 08:00AM  
Mar-25-19 01:30PM  
Mar-21-19 04:05PM  
Mar-18-19 04:05PM  
Feb-21-19 04:05PM  
Feb-06-19 02:38PM  
Feb-01-19 11:30AM  
Jan-09-19 01:30PM  
Dec-26-18 08:00AM  
Dec-24-18 08:00AM  
Nov-20-18 11:13AM  
Nov-19-18 07:40AM  
Nov-16-18 11:56AM  
Nov-08-18 01:00PM  
Nov-07-18 04:05PM  
Nov-05-18 08:00AM  
Nov-01-18 08:00AM  
Oct-29-18 08:00AM  
Oct-22-18 08:00AM  
Oct-18-18 08:00AM  
Oct-04-18 12:15PM  
Sep-28-18 04:01PM  
Sep-26-18 08:00AM  
Sep-25-18 09:26AM  
Sep-24-18 04:01PM  
Sep-21-18 08:51AM  
Sep-20-18 04:05PM  
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes treatments for opioid overdose; alcohol use disorders; acute cannabinoid overdose; and opioid use disorders. The company was formerly known as Lightlake Therapeutics Inc. and changed its name to Opiant Pharmaceuticals, Inc. in January 2016. Opiant Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Santa Monica, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Thomas Thomas T.DirectorSep 04Buy8.055004,0255,000Sep 08 04:01 PM
Thomas Thomas T.DirectorSep 03Buy8.402,50021,0004,500Sep 08 04:01 PM